Sharps Technology

Sharps Technology, Inc. is a U.S.-headquartered medical device company that develops safety syringe products under the Sharps Provensa line. The company designs its syringes to reduce needlestick injuries, prevent reuse and minimize vaccine waste, addressing recognized concerns within healthcare delivery and immunization programs.

Manufacturing takes place in ISO-certified facilities, with products meeting FDA clearance and CE marking standards required for distribution across regulated medical markets. The company's portfolio targets hospitals, clinics, public health agencies and pharmaceutical partners that prioritize compliant single-use injection devices and cold-chain compatible delivery systems.

Beyond its core medical device operations, Sharps Technology has adopted a digital asset treasury strategy centered on the Solana blockchain, positioning cryptocurrency holdings as a structural component of its corporate balance sheet. This dual focus places the company among a small group of small-cap healthcare firms experimenting with on-chain treasury frameworks alongside their primary commercial operations. The combined approach situates Sharps Technology at an intersection of safety-engineered medical hardware and emerging treasury models tied to public blockchain networks, reflecting how some operating companies are integrating digital assets into capital management while continuing to scale their underlying product businesses.